000 01653 a2200469 4500
005 20250517091108.0
264 0 _c20161223
008 201612s 0 0 eng d
022 _a1573-7217
024 7 _a10.1007/s10549-016-3777-0
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDrooger, Jan C
245 0 0 _aToxicity of (neo)adjuvant chemotherapy for BRCA1- and BRCA2-associated breast cancer.
_h[electronic resource]
260 _bBreast cancer research and treatment
_cApr 2016
300 _a557-566 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAnthracyclines
_xadministration & dosage
650 0 4 _aBRCA1 Protein
_xgenetics
650 0 4 _aBRCA2 Protein
_xgenetics
650 0 4 _aBreast Neoplasms
_xdrug therapy
650 0 4 _aChemotherapy, Adjuvant
_xadverse effects
650 0 4 _aChemotherapy-Induced Febrile Neutropenia
_xepidemiology
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aFemale
650 0 4 _aGerm-Line Mutation
650 0 4 _aHumans
650 0 4 _aLinear Models
650 0 4 _aMiddle Aged
650 0 4 _aNeoplasm Recurrence, Local
_xdrug therapy
650 0 4 _aRetrospective Studies
650 0 4 _aTaxoids
_xadministration & dosage
650 0 4 _aYoung Adult
700 1 _aHeemskerk-Gerritsen, Bernadette A M
700 1 _aSmallenbroek, Nyrée
700 1 _aEpskamp, Cynthia
700 1 _aSeynaeve, Caroline M
700 1 _aJager, Agnes
773 0 _tBreast cancer research and treatment
_gvol. 156
_gno. 3
_gp. 557-566
856 4 0 _uhttps://doi.org/10.1007/s10549-016-3777-0
_zAvailable from publisher's website
999 _c25908672
_d25908672